Further research is required to determine (i) why the expression of p75NTR is lost during cancer progression (hypermethylation status) and (ii) if by specifically targeting p75NTR, it is possible to reactivate it and consequently reduce and stop cancer progression. This evidence concerns the gene NGFR and cancer.